LY262691 is a selective CCK-B antagonist with antipsychotic properties. LY262691 decreases the number of spontaneously active A9 and A10 dopamine cells and can be utilized in antipsychotic research[1].
Molecular Weight:
436.30
CAS Number:
[138932-35-1]
Formula:
C22H18BrN3O2
Target:
Cholecystokinin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
